Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
06 2020
Historique:
received: 09 05 2019
accepted: 02 09 2019
pubmed: 7 9 2019
medline: 28 4 2021
entrez: 7 9 2019
Statut: ppublish

Résumé

Peripheral T-cell lymphoma comprises a heterogeneous group of mature non-Hodgkin lymphomas. Their diagnosis is challenging, with up to 30% of cases remaining unclassifiable and referred to as "not otherwise specified". We developed a reverse transcriptase-multiplex ligation-dependent probe amplification gene expression profiling assay to differentiate the main T-cell lymphoma entities and to study the heterogeneity of the "not specified" category. The test evaluates the expression of 20 genes, including 17 markers relevant to T-cell immunology and lymphoma biopathology, one Epstein-Barr virus-related transcript, and variants of

Identifiants

pubmed: 31488561
pii: haematol.2019.226647
doi: 10.3324/haematol.2019.226647
pmc: PMC7271600
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1582-1592

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

N Engl J Med. 2012 Jan 5;366(1):95-6
pubmed: 22216861
J Mol Diagn. 2018 Sep;20(5):677-685
pubmed: 29981867
J Mol Diagn. 2015 Apr 9;:
pubmed: 25891505
Blood. 2019 Apr 11;133(15):1664-1676
pubmed: 30782609
Blood. 2016 Feb 4;127(5):596-604
pubmed: 26574607
Oncotarget. 2016 Oct 4;7(40):65284-65294
pubmed: 27589565
Leuk Lymphoma. 2018 May;59(5):1188-1194
pubmed: 29504866
Clin Lymphoma Myeloma Leuk. 2017 Apr;17(4):193-200
pubmed: 28209473
Blood. 2010 Feb 4;115(5):1026-36
pubmed: 19965671
Blood. 2014 Aug 28;124(9):1473-80
pubmed: 24894770
Haematologica. 2017 Apr;102(4):e148-e151
pubmed: 28082343
Am J Surg Pathol. 2017 Dec;41(12):1581-1592
pubmed: 28945625
J Clin Oncol. 2007 Mar 1;25(7):805-12
pubmed: 17327602
Blood. 2017 Jul 27;130(4):554-557
pubmed: 28522440
Nat Genet. 2014 Feb;46(2):166-70
pubmed: 24413734
J Clin Pathol. 2007 Dec;60(12):1373-7
pubmed: 18042693
Blood. 2014 May 1;123(18):2893-4
pubmed: 24786457
Nat Genet. 2014 Feb;46(2):171-5
pubmed: 24413737
Blood. 2012 Feb 23;119(8):1901-3
pubmed: 22215888
Am J Surg Pathol. 2014 Jun;38(6):768-75
pubmed: 24618604
Semin Cancer Biol. 2014 Feb;24:49-60
pubmed: 24316493
J Mol Diagn. 2017 Nov;19(6):892-904
pubmed: 29054399
Cancer. 2014 Jul 1;120(13):1993-9
pubmed: 24706502
Am J Hematol. 2019 Jun;94(6):628-634
pubmed: 30829413
Blood. 2014 May 8;123(19):2915-23
pubmed: 24632715
Blood. 2012 Aug 16;120(7):1466-9
pubmed: 22760778
Blood. 2007 Jun 1;109(11):4952-63
pubmed: 17284527
Blood. 2014 May 8;123(19):3007-15
pubmed: 24497534
J Clin Oncol. 2017 Jun 20;35(18):2008-2017
pubmed: 28459613

Auteurs

Fanny Drieux (F)

INSERM U1245, Centre Henri Becquerel, Rouen, France.
Service d'Anatomie et Cytologie Pathologiques, Centre Henri Becquerel, Rouen, France.
INSERM U955 and Université Paris-Est, Créteil, France.

Philippe Ruminy (P)

INSERM U1245, Centre Henri Becquerel, Rouen, France philippe.ruminy@chb.unicancer.fr.

Ahmad Abdel-Sater (A)

INSERM U1245, Centre Henri Becquerel, Rouen, France.

François Lemonnier (F)

INSERM U955 and Université Paris-Est, Créteil, France.
Unité Hémopathies Lymphoïdes, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.

Pierre-Julien Viailly (PJ)

INSERM U1245, Centre Henri Becquerel, Rouen, France.

Virginie Fataccioli (V)

INSERM U955 and Université Paris-Est, Créteil, France.

Vinciane Marchand (V)

INSERM U1245, Centre Henri Becquerel, Rouen, France.

Bettina Bisig (B)

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Audrey Letourneau (A)

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Marie Parrens (M)

Service d'Anatomie et Cytologie Pathologiques, Hôpital Haut-Lévêque, CHU de Bordeaux, France.

Céline Bossard (C)

Service d'Anatomie et Cytologie Pathologiques, CHU de Nantes, France.

Julie Bruneau (J)

Service d'Anatomie et Cytologie Pathologiques, Hôpital Universitaire Necker - Enfants Malades, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.

Pamela Dobay (P)

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Liana Veresezan (L)

INSERM U1245, Centre Henri Becquerel, Rouen, France.
Service d'Anatomie et Cytologie Pathologiques, Centre Henri Becquerel, Rouen, France.

Aurélie Dupuy (A)

INSERM U955 and Université Paris-Est, Créteil, France.

Anaïs Pujals (A)

INSERM U955 and Université Paris-Est, Créteil, France.
Département de Pathologie, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.

Cyrielle Robe (C)

INSERM U955 and Université Paris-Est, Créteil, France.

Nouhoum Sako (N)

INSERM U955 and Université Paris-Est, Créteil, France.

Christiane Copie-Bergman (C)

INSERM U955 and Université Paris-Est, Créteil, France.
Département de Pathologie, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.

Marie-Hélène Delfau-Larue (MH)

INSERM U955 and Université Paris-Est, Créteil, France.
Département d'Hématologie et Immunologie Biologique, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.

Jean-Michel Picquenot (JM)

INSERM U1245, Centre Henri Becquerel, Rouen, France.
Service d'Anatomie et Cytologie Pathologiques, Centre Henri Becquerel, Rouen, France.

Hervé Tilly (H)

INSERM U1245, Centre Henri Becquerel, Rouen, France.

Richard Delarue (R)

Service Hématologie Adultes, Hôpital Universitaire Necker - Enfants Malades, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.

Fabrice Jardin (F)

INSERM U1245, Centre Henri Becquerel, Rouen, France.

Laurence de Leval (L)

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

Philippe Gaulard (P)

INSERM U955 and Université Paris-Est, Créteil, France philippe.gaulard@aphp.fr.
Département de Pathologie, Groupe Hospitalier Henri Mondor, AP-HP, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH